Confluence Investment Management LLC acquired a new position in JPMorgan Chase & Co. (NYSE:JPM) in the fourth quarter, ...

Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) announced that it will present at the 43rd Annual J.P. Morgan Healthcare ...

Shares of JPMorgan Chase & Co. JPM rallied 1.37% to $243.28 Friday, on what proved to be an all-around favorable trading ...

US statute makes it clear that American presidents are granted the power to kill a deal they deem a threat to national ...

Interested parties may access a live webcast and replay of the presentation by visiting the Inari Medical investor relations ...

JPMorgan (JPM) the only major U.S. bank left in the United Nations-backed Net-Zero Banking Alliance, is considering withdrawing from it, The ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the ...

Internet Posting of Information Treace routinely posts information that may be important to investors in the“Investor Relations” section of its website at . The Company encourages investors and ...

RADNOR, Pa., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the 43 rd ...

Marianne Lake, CEO of consumer and community banking at JPMorgan Chase, worries most about an uneven playing field, where “as ...

JPMorgan Chase & Co (JPM) stock saw a modest uptick, ending the day at $239.71 which represents a slight increase of $0.39 or 0.16% from the prior close of $239.32. The stock opened at $240.05 and ...